Compound for organic electric element, organic electric element comprising the same and electronic device thereof
US-2018141957-A1 · May 24, 2018 · US
US10873034B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10873034-B2 |
| Application number | US-201715413831-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 24, 2017 |
| Priority date | Feb 11, 2016 |
| Publication date | Dec 22, 2020 |
| Grant date | Dec 22, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A condensed cyclic compound represented by Formula 1: Ar 1 -(L 1 ) a1 -Ar 2 Formula 1 wherein, in Formula 1, Ar 1 , Ar 2 , L 1 , and a1 are the same as described in the specification.
Opening claim text (preview).
What is claimed is: 1. A condensed cyclic compound represented by Formula 1: wherein, in Formulae 1, 2-2, 2-4, 3-12, 3-15, and 3-16, Ar 1 is selected from groups represented by Formulae 2-2 and 2-4; Ar 2 is selected from groups represented by Formulae 3-12, 3-15, and 3-16; L 1 is selected from a substituted or unsubstituted C 6 -C 60 arylene group and a substituted or unsubstituted C 1 -C 60 heteroarylene group; a1 is selected from 1, 2, and 3; X 21 is selected from O, S, C(R 22 )(R 23 ), Si(R 22 )(R 23 ), Ge(R 22 )(R 23 ), and P(═O)(R 22 ); X 31 is selected from O, S, N(R 34 ), C(R 34 )(R 35 ), Si(R 34 )(R 35 ), and Ge(R 34 )(R 35 ); provided that when Ar 1 is Formula 2-4 and Ar 2 is Formula 3-12, when X 21 is S, then X 31 is selected from O, S, C(R 34 )(R 35 ), Si(R 34 )(R 35 ), and Ge(R 34 )(R 35 ); A 21 is selected from a C 5 -C 20 carbocyclic group and a C 4 -C 20 heterocyclic group; Y 21 is selected from a substituted or unsubstituted C 6 -C 60 aryl group and a substituted or unsubstituted C 1 -C 60 heteroaryl group; R 21 to R 23 , R 31a to R 31d , R 32a to R 32d , R 33a to R 33d , R 34 , and R 35 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group; b21 is selected from 1, 2, 3, 4, 5, 6, 7, and 8; and * denotes a binding site to a neighboring atom. 2. The condensed cyclic compound of claim 1 , wherein L 1 is selected from a phenylene group, a naphthylene group, a pyridinylene group, a pyrimidinylene group, a pyrazinylene group, a pyridazinylene group, and a triazinylene group; and a phenylene group, a naphthylene group, a pyridinylene group, a pyrimidinylene group, a pyrazinylene group, a pyridazinylene group, and a triazinylene group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, and a naphthyl group. 3. The condensed cyclic compound of claim 1 , wherein L 1 is selected from a single bond and groups represented by Formulae 4-1 to 4-15: wherein, in Formulae 4-1 to 4-15, R 41 is selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, and a naphthyl group; b41 is selected from 1, 2, 3, and 4; b42 is selected from 1, 2, 3, 4, 5, and 6; and * and *′ each independently denote a binding site to a neighboring atom. 4. The condensed cyclic compound of claim 1 , wherein a1 is 1. 5. The condensed cyclic compound of claim 1 , wherein (L 1 ) a1 is selected from groups represented by Formulae 5-1 to 5-3: wherein, in Formulae 5-1 to 5-3, * and *′ each independently denote a binding site to a neighboring atom. 6. The condensed cyclic compound of claim 1 , wherein A 21 is selected from a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, a pyridine group, a pyrimidine group, a pyrazine group, a quinoline group, an isoquinoline group, 2,6-naphthyridine group, 1,8-naphthyridine group, 1,5-naphthyridine group, 1,6-naphthyridine group, 1,7-naphthyridine group, 2,7-naphthyridine group, a quinoxaline group, a phthalazine group, a quinazoline group, and a cinnoline group. 7. The condensed cyclic compound of claim 1 , wherein A 21 is selected from a benzene group and a naphthalene group. 8. The condensed cyclic compound of claim 1 , wherein Y 21 is selected from a phenyl group, a biphenyl group, a terphenyl group, a pentalenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an indolyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, and a triazinyl group; and a phenyl group, a biphenyl group, a terphenyl group, a pentalenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an indolyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, and a triazinyl group, each substituted with at least one selected from deuterium, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title
Delayed fluorescence emission · CPC title
Polycyclic condensed heteroaromatic hydrocarbons · CPC title
containing organic luminescent materials · CPC title
non-luminescent particle coatings or suspension media · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.